XIN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shandong Xinhua Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 0.61 EUR

Market Cap: €1.2B

	Shandong Xinhua Pharmaceutical Co Ltd F:XIN	CN
S	Shandong Xinhua Pharmaceutical Co Ltd SWB:XIN	CN

Profitability Summary

Shandong Xinhua Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

23%

Declining Gross Margin

28% > 17%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

7% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 3%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.